Yuling Luo, Ph.D., is a venture partner at Illumina Ventures and CEO of Alamar Biosciences. He founded Advanced Cell Diagnostics, acquired by Bio-Techne, and co-founded Panomics, acquired by Affymetrix. He studied at the University of Science & Technology of China and Case Western Reserve University.
At firms with a similar stage, sector and check size.



One email when Yuling's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckYuling Luo, Ph.D., is a venture partner at Illumina Ventures and CEO of Alamar Biosciences. He founded Advanced Cell Diagnostics, acquired by Bio-Techne, and co-founded Panomics, acquired by Affymetrix. He studied at the University of Science & Technology of China and Case Western Reserve University.
Illumina Ventures has not reported a check size. It invests at seed, series a.
A warm intro from a founder Illumina Ventures backed works best.
senior scientist at Exelixis; vice president, Functional Genomics and chief scientific officer at Panomics; founder, president and CEO at Advanced Cell Diagnostics (ACD); founder, chairman and CEO at Alamar Biosciences.
Last updated 2026-10-15. Is this you? Ask for a correction.